Medtronic Spinal and Biologics
Clinical trials sponsored by Medtronic Spinal and Biologics, explained in plain language.
Now part of
Medtronic plc
MDT
NYSE
A division of Medtronic focused on spinal and biologic products.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New bone graft study aims to improve spine surgery outcomes Results expected Jul 2027 (estimated)